PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.
Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford, California cDivision of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
Alison E
AE
Fohner
Alex
A
Sparreboom
Russ B
RB
Altman
Teri E
TE
Klein
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects* / Q000472:pathogenicity; D017291:Clarithromycin / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D018942:Macrolides / Q000737:chemistry / Q000627:therapeutic use*; D010597:Pharmacogenetics; D015398:Signal Transduction / Q000187:drug effects
D000900:Anti-Bacterial Agents; D018942:Macrolides; D004917:Erythromycin; D017963:Azithromycin; D017291:Clarithromycin